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The Tat system preferentially transports correctly folded proteins across the bacterial 
membrane although little is known of the proofreading mechanism. Most research has 
focused on TatABC systems from Gram-negative bacteria, especially Escherichia coli, and 
much less is known of the TatAC-type systems from Gram-positive organisms. We have 
previously shown that the Bacillus subtilis TatAdCd system is functional in an E. coli tat 
null background and able to transport TorA-GFP and native TorA (TMAO reductase); here, 
we examined its ability to transport other proteins bearing a TorA signal sequence. We 
show that whereas E. coli TatABC transports a wide range of biotherapeutics including 
human growth hormone, interferon α2b, a VH domain protein and 2 different scFvs, 
TatAdCd transports the scFvs but completely rejects the other proteins. The system also 
rejects two native E. coli substrates, NrfC and FhuD. Moreover, we have shown that 
TatABC will transport a wide range of folded scFv variants with the surface altered to 
incorporate multiple salt bridges, charged residues (5 glutamate, lysine or arginine), or 
hydrophobic residues (up to 6 leucines). In contrast, TatAdCd completely rejects many of 
these variants including those with 5 or 6 added Leu residues. The combined data show 
that the TatABC and TatAdCd systems have very different substrate selectivities, with the 
TatAdCd system displaying an extreme level of selectivity when compared to the E. coli 
system. The data also provide a preliminary suggestion that TatAdCd may not tolerate 









Bacteria use two main systems to transport proteins across the plasma membrane: the 
Sec and Tat pathways. The two systems use completely different mechanisms to achieve 
transmembrane translocation; the Sec pathway transports proteins in an obligatorily 
unfolded state, while the Tat pathway is specialised for the transport of fully folded 
proteins. The precise mechanism of the Tat system is still a matter of debate, but the 
available evidence indicates that in Gram-negative bacteria, substrates bearing a Tat 
signal peptide interact initially with a TatBC complex, which then assembles with a 
separate TatA complex to form the full translocation system [1,2].  
 
In Gram-negative bacteria, a number of Tat substrates are redox proteins that bind any of 
a range of cofactors, such as FeS or NiFe centres. Since these cofactors are only inserted 
in the cytoplasm, there is a clear need for substrate 'proofreading' to avoid exporting 
incompletely assembled proteins, and a range of assembly chaperones have been 
identified, several being substrate-specific [3]. However, the Tat proofreading systems go 
much further than this, and numerous studies have shown that incorrectly folded proteins - 
even heterologous proteins that Tat does not encounter in vivo - are only transported in a 
correctly folded state [4-7]. In these cases, incorrectly folded substrates are quantitatively 
rejected. 
 
Tat systems from Gram-positive organisms are usually different in structure due to the lack 
of a TatB subunit, with the TatA subunit being bifunctional and able to fulfil the functions of 
both TatA and TatB from Gram-negative organisms, probably as a result of an early gene 
duplication event [8-10]. B. subtilis has two Tat systems, TatAdCd and TatAyCy, each with 
different substrate specificities. The only native substrate of the TatAdCd system is the 
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phosphodiesterase PhoD, but the system has been expressed in an E. coli tat null mutant 
where it provides a partial complementation [9]. In this strain, TatAdCd was shown to 
export a Tat signal peptide- (TorA-) GFP construct, as well as the native TorA protein 
(TMAO reductase, an 86 kDa protein bearing a complex molybdenum-based cofactor). 
Virtually nothing is known about the substrate proofreading activities of Tat systems from 
Gram-positive organisms, and we considered it possible that some of these systems may 
not engage in such extensive substrate proofreading - the TatAdCd system, for example, 
has evolved to transport only a single protein and may not require a rigorous quality 
control system.  
 
In this study we have tested the ability of TatAdCd to transport a range of heterologous 
proteins that have all been shown to be exported by the E. coli TatABC system. These 
proteins are all disulphide bond-containing proteins, which raises an additional level of 
complexity because disulphide bonds cannot form in the reducing cytoplasm of wild type 
E. coli strains [11]. However, several of these proteins have been shown to be exported by 
TatABC because they form near-native structures even without disulphide bonds [12]. One 
of the substrates does require prior disulphide bond formation to be exported by Tat, and 
this substrate was expressed in ÔCyDisCoÕ (Cytoplasmic Disulphide formation in E. coli) 
strains that promote the catalysis of disulphide bonds via a yeast mitochondrial thiol 
oxidase (Erv1p) and human protein disulphide isomerase (PDI) [13]. 
 
This range of substrates, together with a series of mutated versions of one scFv, were 
tested for export by TatAdCd with surprising results: the system efficiently exported two 
different scFvs but rejected a series of other biotherapeutic proteins. Moreover, we also 
tested a range of scFv mutated forms, all of which are efficiently exported by TatABC, and 
found that a large proportion were totally rejected by TatAdCd. The combined data 
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demonstrate that the TatAdCd system exhibits an extreme level of substrate selectivity 
when compared with systems from Gram-negative bacteria. 
 
Materials and Methods 
 
Materials  
All chemicals, unless specified otherwise, were obtained from Sigma Chemical Co. Ltd. 
(Poole, Dorset, UK) and were of analytical grade.  
 
Plasmids and bacterial strains 
scFvM constructs were as described in [14] except for the P172S mutant which was 
generated through Quick change PCR (see below), and subsequently cloned into the 
vector pYU49. Prior to cloning into pYU49, a 5Õ NdeI site, a 3Õ hexahistidine-tag and a 3Õ 
BamHI site were added through successive rounds of PCR. PCR primers were: 
Primer Name Sequence Use 
scFvMwtP172SF T CAG CAG AAA TCG GGT CAG GCA CCG CGT TAC CT  Forward 
primer 
scFvMwtP172SR TC GCG TGG TAT CAG CAG AAA TCG GGT CAG GCA C  Reverse 
primer 
 
Overproduction of pCM11: preFhuD was cloned as in [15] into pBAD24 with a 5Õ EcoR1 
site, 3Õhexahisdidine-tag and a 3Õ Pst1 site for the native protein export studies [16]. 
Primer Name Sequence Use 
 GCATATGAATTCATGAGCGGCTTACCTC Forward 
primer 





All constructs were amplified using Phusion high fidelity DNA polymerase (New England 
Biolabs). Products for pYU49 were digested with Nde1 and BamH1 and inserted into 
pYU49 with a C-terminal hexahistinidine tag. TatABC and TatAdCd were digested with 
Nde1 and Xho1 and inserted into pLysSBAD, with a C-terminal Strep tag II tag. All plasmid 
purification was performed using the QIAprep spin miniprep kit (Qiagen) and purified from 
agarose gels using the gel extraction kit (Qiagen), according to the protocol. All plasmids 
were fully sequenced (see Table 1). Plasmids encoding Tor-hGH, TorA-IFN and TorA-VH 
domain are described in [13]. Table 1 lists the plasmids used in this study. 
 
Growth conditions 
Following cotransformation of pYU49 and pLysSBAD, a single colony was used to 
inoculate 5 ml of LB containing 1 mM chloramphenicol and 1 mM ampicillin and grown 
overnight at 37¡C, 200 rpm. This culture was used to inoculate 50 mL of LB in 250 mL 
conical flasks to OD600= 0.05 and were grown until OD600= 0.5 at 37¡C, 200 rpm with the 
same antibiotics as previously mentioned. Cells were then induced with 0.5 mM IPTG and 
0.5 mM arabinose and left for 3 hours at 30¡C (unless stated otherwise).  
 
Fractionation 
Cells were standardized to the equivalent of OD600=10 and then collected by 
centrifugation (3000rpm, 10 min). The periplasm (P) was collected using 
EDTA/lysozyme/cold osmotic shock and centrifugation [13]. The resulting pellet was  
washed and resuspended in 50mM Tris-acetate pH8.2, 2.5mM EDTA pH8.0 before 
sonication (4-6 X 10 sec) at 8µm amplitude (Soniprep 150plus, Sanyo Gallenkamp, 
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Loughborough, UK). The sonicate was centrifuged for 30 min at 70,000rpm, 4¡C and the 
supernatant collected as ÔCytoplasmic fractionÕ C. The ÔMembrane fractionÕ M is prepared 
by resuspending the pellet in buffer as before [13] 
 
Detection  
Following fractionation protein samples were analysed by SDS-PAGE. Protein was then 
electrotransferred onto PVDF membrane (Amersham, UK) to be immunoblotted with C-
terminal his antibodies (blocked with PBS-T containing 5% (w/v) dried skimmed milk for 1 
h). The membranes were washed with PBS-T before a 1 h incubation with the primary 
antibody, Anti-his C term (Life Technologies, CA, USA), Membrane was washed prior to a 
1 hour incubation with the secondary antibody, Anti-mouse IgG (H+L) HRP conjugate 
(Promega, WI, USA). Membranes were washed and proteins were visualized using an 
ECL (enhanced chemiluminescence) detection system (BioRad, Herts, UK) subject to the 




Partial complementation of the ΔtatABCDE filamentous cell phenotype upon expression of  
the B. subtilis TatAdCd machinery  
E. coli ΔtatABCDE (Δtat) cells exhibit a range of phenotypic effects, highlighting the 
important roles of the Tat system in this organism. These effects include decreased 
motility, increased sensitivity to detergents and impaired septation [17]. With the latter, 
light microscopic analysis showed that Δtat strains display defective cell division, forming 
chains up to 10 cells long [18,19]. This phenotype is complemented when the TatABC 
machinery is expressed from a plasmid. However, while the B. subtilis TatAdCd system is 
able to function in Δtat strains, its expression does not fully complement the phenotype 
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[20]; at most stages of lab-scale growth the filamentous phenotype is still apparent. It has 
been suggested that this partial rescue reflects the ability of TatAdCd to efficiently 
recognize GFP constructs bearing the E. coli Tat signal peptide, while at least some other 
E. coli signal peptides are not recognized [20]. This could explain why a number of E. coli 
Tat substrates are mislocalised in these TatAdCd-expressing cells [21]. 
 
In this study we analysed the export of a number of proteins, all bearing the TorA signal 
peptide, in Δtat cells expressing pTatABC (E. coli) or pTatAdCd (B. subtilis). The operons 
were expressed from a different plasmid to that used in previous studies (pLysS-BAD; see 
Materials and Methods) and we first confirmed that Δtat cells expressing pTatAdCd 
exhibited the previously-observed filamentous phenotype. Fig. 1 confirms that the Δtat 
strain expressing TatAdCd does indeed show the characteristic filamentous phenotype, 
whereas expression of TatABC complements this phenotype and single cells are generally 
observed.  
 
TatAdCd fails to export a range of proteins that are exported by TatABC 
Δtat cells expressing TatAdCd have been shown to export TorA-GFP but to date this is the 
only heterologous protein tested for export by TatAdCd when expressed in the E. coli Δtat 
strain. To further analyse the export capacity of TatAdCd we tested for export of a range of 
proteins, including human growth hormone (hGH), interferon Ș2b (IFN), a single chain 
antibody variable fragment (scFv) and a VH domain construct [13, 22]. All of these 
constructs have been successfully exported by TatABC in wild type E. coli cells, and it was 
further shown that none of them require prior disulphide bond formation for export by Tat. 
All proteins tested were expressed on a pET23-based plasmid system either with or 
without the CyDisCo components, Erv1p and PDI [12]. After expression, cells were 
fractionated to yield samples of cytoplasm, membrane and periplasm (C, M, P). Fig. 2 
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shows immunoblots using antibodies to the His-tagged target proteins in tests carried out 
in the absence of CyDisCo components (identical results were obtained in CyDisCo 
strains; data not shown).  
 
TorA-hGH (23.6 kDa), TorA-IFN (20.7 kDa) and a TorA-VH domain construct (9.5 kDa) are 
detected in TatABC-expressing cells, with the vast majority of protein exported to the 
periplasm and present as mature, processed protein, while no export is observed in Δtat 
cells, as expected. Unexpectedly, TatAdCd exported none of the proteins, with essentially 
no mature protein detected in the periplasm samples. Only low levels of protein are 
present in the cytoplasm or membrane fractions, presumably because these proteins are 
subject to proteolysis within the cytoplasm, as reported previously [12]. 
 
We also tested twio native E. coli Tat substrates, namely NrfC and FhuD. Both have been 
shown to be exported by the Tat export pathway [15,16] and the left hand panels of Fig. 3 
show that they are exported to the periplasm with very high efficiency in wild type cells 
(WT) under these expression conditions. In contrast, essentially no export is observed in 
Δtat cells expressing TatAdCd, and the protein is observed primarily in the membrane 
fraction (which includes insoluble material).  
 
TatAdCd efficiently exports two different scFv proteins 
We next tested the ability of TatAdCd to export two TorA-scFv constructs (Fig. 4). One 
scFv (28.9 kDa) is raised against the omega peptide of β-galactosidase [23] and the other 
(27 kDa) is described in [14,24]; these scFvs are termed scFvO and scFvM, respectively. 
Export of TorA-scFvO was reported in [12] and its export was shown to be CyDisCo-
independent. In contrast, we recently carried out a study of the export of TorA-scFvM and 
showed that export is strongly dependent on prior disulphide bond formation [14]. 
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The upper panel of Fig. 4 shows that both scFvs are exported by TatAdCd in CyDisCo-
expressing cells, with export of scFvM indeed more efficient in TatAdCd-expressing cells 
than in TatABC-expressing cells. Two bands are present in the C and M fractions; the 
higher band is precursor protein while the lower band is believed to represent 
proteolytically clipped protein. The scFvs differ in their dependence on disulphide bond 
formation for export by TatAdCd. TorA-scFvO can be exported in the absence of CyDisCo 
by the E. coli TatABC [14]; the lower panel of Fig. 4 shows that scFvM is exported well in 
the presence of the CyDisCo components, whereas virtually no export is observed in wild 
type cells (-CyDisCo). These data resemble those obtained with TatABC-expressing cells 
in a previous study, where export of TorA-scFvM was shown to be far more efficient in 
CyDisCo strains  [14], so in this case the TatABC and TatAdCd systems do exhibit similar 
preferences in terms of substrate structure. 
 
Effects of scFvM surface mutations: TatAdCd is far more selective than TatABC 
In order to probe the proofreading activity of the E. coli TatABC system, we recently tested 
a range of variants of scFvM. Most of the variants were shown to be properly folded, with 
the mutations designed to change the hydrophobicity or charge on the surface [14]. In the 
first group, uncharged residues were substituted to create 1, 2 or 3 Lys-Glu salt bridges 
(SB1, SB2, SB3). This increased the surface charge but in a net-neutral manner. In the 
2nd group, 5 uncharged surface residues were substituted with either Lys, Glu or Arg to 
create a more positively- or negatively-charged area (denoted 5Lys, 5Glu, and 5Arg). In 
the third group, 4, 5 or 6 neutral, polar surface residues were substituted with leucine, with 
the substitutions made in the N-terminal domain (mutants 4N-Leu, 5N-Leu and 6N-Leu). 
These changes thus create a domain that is much more hydrophobic (see Supplementary 
Figure 1 for further details).  
  11 
 
Fig. 5 shows that the 'SB' mutants in group 1 were all exported by TatABC as shown 
previously [14]. SB1, with one salt bridge, is exported with particularly high export 
efficiency although it is notable that this mutant is almost totally degraded in the Δtat cells. 
However, SB2 and SB3 are also exported with reasonable efficiency by TatABC.  The 
data obtained with TatAdCd are slightly different: SB1 and SB2 are exported to a 
reasonable extent, but no export of SB3 is observed.  
 
The second group of mutations (Fig. 6) which create a highly positively- or negatively-
charged area, have interesting effects. 5Lys, 5Glu and 5Arg are all exported by TatABC, 
with the 5Glu variant exported more efficiently than 5Lys. Although 5Glu and 5Arg are 
exported by TatAdCd, no export of 5Lys is observed. Given this result, we sought to test 
whether the TatAdCd inherently discriminates against Lys residues, and we therefore 
constructed another mutant in which 5 different Arg residues were substituted by Lys. Data 
obtained with this protein (5R>K) are shown in the bottom panel of Fig. 6. The results 
show that the mutant is exported well by TatABC and, to a very low extent, by TatAdCd. 
On the basis of these data we believe that TatAdCd does not have an inherent aversion to 
Lys residues, and probably rejects the 5Lys mutant for other, undefined reasons. 
 
Tests with the 'hydrophobic patch' group of mutant scFvM proteins, in which 4, 5 or 6 
charged surface residues were substituted with leucine, are shown in Fig. 7. The results 
show that the substitutions had little effect on TatABC export, with all 3 substrates 
exported well. In contrast, mutant 4N-Leu is exported only very weakly by TatAdCd, while 
5N-Leu and 6N-Leu are not exported at all. Clearly, these substitutions render the scFvM 
particularly unsuitable for transport by TatAdCd. 
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Overall, these data show that TatAdCd exhibits a far more stringent level of substrate 
selectivity when compared with TatABC, and the data therefore raise the interesting 
possibility that the system has an inherent tendency to reject substrates bearing exposed 
hydrophobic domains.  
 
TatAdCd rejects misfolded variants of scFvM 
While the data in Figs. 2-6 point to an unusual level of substrate selectivity by TatAdCd, 
these tests did not address the question of whether TatAdCd rejects misfolded proteins 
because virtually all of the substrates were shown to be highly folded. We therefore tested 
TatAdCd with another scFvM variant that contains an unfolded region that causes it to be 
quantitatively rejected by TatABC [14]. This mutant (Ô26tailÕ) has 26 residues appended to 
the C-terminus of the scFvM, and this unfolded section is clearly identified as 
'inappropriate' and rejected by TatABC [14]. Fig. 8 shows that this mutant is likewise 
completely rejected by TatAdCd. The other is a P172S substitution that is located between 
the two major scFvM domains (shown in Fig. 7). We expected this mutation to cause a 
destabilisation in the overall structure but the variant is transported with high efficiency by 
TatABC as shown. However, Fig. 8 also shows that this variant is not exported at all by 
TatAdCd, strongly suggesting that TatAdCd is more sensitive than TatABC in responding 
to changes in the substrate conformation. We conclude from these data that TatAdCd 





The primary aim of this study was to further investigate the capabilities of the B. subtilis  
TatAdCd system, and to compare its substrate selectivity and proofreading abilities to 
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those of the E. coli TatABC system. The expression of B. subtilis TatAdCd is co-regulated 
with its single substrate PhoD (a phosphodieasterase) from the phoD operon in phosphate 
starvation conditions [25]. A second system, TatAyCy, exports other Tat substrates [26]. 
However, when expressed in E. coli ΔtatABCDE cells, TatAdCd has been shown to 
partially complement the E.coli Δtat phenotype and to efficiently export TorA-GFP and the 
native TorA protein (TMAO reductase; an 86 kDa MGD-containing protein). TatAdCd is 
clearly capable of transporting diverse proteins and we set out to compare this Gram-
positive TatAC-type system with the well-studied E. coli TatABC system.  
 
In addition to probing any mechanistic differences, these systems also have potential for 
biotechnological exploitation, and a second aim was to understand the capabilities of 
TatAdCd in this context. Previous results during batch fermentation using a model Tat 
substrate (TorA-GFP) showed export to the periplasm and also release into the culture 
medium [20]. This platform could decrease downstream purification needs and shield the 
protein from proteases within the cell. A range of biopharmaceuticals, including hGH, IFN, 
scFvs and a VH domain have been shown to be exported by TatABC [12,13] but they 
have not been tested for export by TatAdCd.  
 
This study has shown for the first time that a Tat system from a Gram-positive organism 
can exhibit a far more stringent level substrate specificity when compared with its E. coli 
counterpart. Of the biotherapeutics described above, only the scFvs were exported by 
TatAdCd even though all of the above proteins are exported with high efficiency by 
TatABC using the TorA signal peptide. No export of IFN, hGH or VH domain protein to the 
periplasm was observed via TatAdCd. It is unclear why TatAdCd is unable to transport 
these proteins. The proteins are all smaller than GFP and substantially smaller than PhoD 
(62 kDa) and TorA (86 kDa) so size is not the issue.  
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The export of two different scFvs has also been shown via TatABC previously [13] and 
[14] and this study has shown that TatAdCd can also export both of these proteins. 
Moreover, export one of the proteins (scFvM) by TatABC is largely CyDisCo-dependent, 
and this study has shown that the same applies for export by TatAdCd. We previously 
explored the phenomenon of Tat Ôquality controlÕ by analyzing the ability of TatABC to 
export different variants of scFvM, which has a well-characterized structure. We found that 
a variety of surface changes, leading to the addition of salt bridges, changes in charge 
distribution and the creation of hydrophobic regions, were all tolerated by TatABC with 
minimal effect on export. Using the same plasmids under the same growth conditions and 
methods, we observed complete rejection or significantly decreased export of most of 
these scFv variants when tested with TatAdCd.  
 
Changing the surface charge on the scFv gives clear-cut data but it is difficult to discern 
the underlying reasons. The presence of 1 or 2 salt bridges (variants SB1 and SB2) is 
tolerated by TatAdCd, whereas the SB3 variant with 3 salt bridges is completely rejected; it 
is, however, unclear whether this mutant is rejected because of the position of the third salt 
bridge or because of structural changes The 5Glu variant (5 surface Glu residues added) 
is exported with reasonable efficiency whereas the 5Lys variant is completely rejected. 
Further tests would be required before any conclusions can be reached regarding 
TatAdCd's preferences for substrate surface charge.  
 
Increases in surface hydrophobicity, however, appear to provide a clearer picture. Variants 
4N-Leu, 5N-Leu and 6N-Leu, in which the surface of the N-terminal domain is rendered 
increasingly hydrophobic, are all exported well by TatABC but 4N-Leu is exported only 
very weakly by TatAdCd and the 5N-Leu and 6N-Leu proteins are wholly rejected. These 
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data suggest that the TatAdCd proofreading mechanism may reject substrates in which 
the hydrophobicity is above a certain threshold, with the corresponding threshold for 
TatABC perhaps being set at a significantly higher level. However, further studies are 
required to systematically explore these possibilities before a definitive conclusion can be 
drawn. Nevertheless, the present study does show that while the TatABC and TatAdCd 
systems can both transport certain proteins, they have very different substrate selectivity 
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Figure 1. TatAdCd does not complement the filamentous phenotype of Δtat cells. 
The figure shows microscope images of ΔtatABCDE cells (top panels) and the same cells 
expressing TatABC or TatAdCd from the pLysS-BAD plasmid, after 2 or 5 hours of 
induction with arabinose (left and right images, respectively). The images show that 
TatABC complements the filamentous phenotype of Δtat cells whereas TatAdCd does not. 
 
Figure 2. TatAdCd fails to export human growth hormone, interferon and VH domain 
protein constructs. TorA-hGH, TorA-IFN and TorA-VH domain constructs were 
expressed in Δtat cells and in Δtat cells expressing TatABC or TatAdCd. After 3 h 
induction the cells were fractionated to yield cytoplasm, membrane or periplasm samples 
(C, M, P). The samples were subjected to immunoblotting using antibodies to the C-
terminal His tag on the target proteins. Mobility of mature target proteins is indicated on 
the right; the mobilities of molecular mass markers (in kDa) are shown on the left. 
 
Figure 3. TatAdCd fails to export two native E. coli Tat substrates 
The precursor forms of E. coli NrfC and FhuD were expressed in wild type cells (WT) or 
Δtat cells expressing TatAdCd as indicated. After 3 h induction the cells were fractionated 
to yield cytoplasm, membrane or periplasm samples (C, M, P). The samples were 
subjected to immunoblotting using antibodies to the C-terminal His tag on the target 
proteins. Mobility of mature target proteins and the precursor forms is indicated on the 
right; the mobilities of molecular mass markers (in kDa) are shown on the left. 
 
Figure 4. TatAdCd efficiently exports two different scFvs. Upper panels: 2 different 
scFvs, designated scFvO and scFvM, were expressed with an N-terminal TorA signal 
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peptide in Δtat cells and in Δtat cells expressing TatABC or TatAdCd together with the 
CyDisCo components Erv1p and PDI. After 3 h induction the cells were fractionated to 
yield cytoplasm, membrane or periplasm samples (C, M, P). Lower panel: TorA-scFvM 
was expressed in Δtat cells expressing TatAdCd in the presence or absence of the 
CyDisCo components Erv1p and PDI. After 3 h induction the cells were fractionated to 
yield cytoplasm, membrane or periplasm samples (C, M, P). The samples were subjected 
to immunoblotting using antibodies to the C-terminal His tag on the target proteins. 
Mobility of mature target proteins is indicated on the right; the mobilities of molecular mass 
markers (in kDa) are shown on the left. 
 
Figure 5. Differential export of surface salt-bridge-containing scFvM variants by 
TatABC and TatAdCd. TorA-scFvM variants SB1, SB2 and SB3 were expressed in Δtat, 
TatABC- or TatAdCd-expressing CyDisCo cells, and samples were fractionated and 
immunoblotted as detailed in Figure 4. Mobilities of mature-size SB1, SB2 and SB3 are 
indicated. 
 
Figure 6. Differential export of scFvM variants containing introduced Glu-, Lys- or 
Arg-rich domains by TatABC and TatAdCd. TorA-scFvM variants 5Lys, 5Glu or 5Arg, 
and a further variant containing 5 Arg to Glu substitutions, were expressed in Δtat, 
TatABC- or TatAdCD-expressing CyDisCo cells, and samples were fractionated and 
immunoblotted as detailed in Figure 4. Mobilities of mature-size proteins are indicated. 
 
Figure 7. scFvM variants with increased surface hydrophobicity are transported by 
TatABC but rejected by TatAdCd. TorA-scFvM variants 4N-Leu, 5N-Leu and 6N-Leu 
were expressed in Δtat, TatABC- or TatAdCD-expressing CyDisCo cells, and samples 
were fractionated and immunoblotted as detailed in Figure 4. Mobilities of mature-size 
  21 
proteins are indicated. 
 
Figure 8. TatAdCd rejects scFvM variants that are misfolded. Top left: homology 
modelled structure of scFvM with Pro172 indicated. TorA-scFvM variants P172S and 26tail 
(containing a 26-residue C-terminal extension), were expressed in TatAdCD-expressing 
CyDisCo cells, and the P172S mutant was also expressed in TatABC-expressing CyDisCo 
cells (top right). Samples were fractionated and immunoblotted as detailed in Figure 4. 
Mobilities of mature-size proteins are indicated. 
 
Supplementary Figure 1. Surface charge model of scFvM highlighting key residues 
altered in this study. (A) and (B) show the unmodified protein in two different projections. 
(C): hydrophilic residues were substituted by Leu (yellow) to create 'hydrophobic patch' 
mutants; the image shows the 5N-Leu mutant. (D): other changes involved substitution of 
surface residues to create Lys-Glu salt bridge pairs or patches of charge (green) or 
changes to the Arg/Lys content (pink). Full details are given in [14]. 
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